Accessibility StatementSkip Navigation Gross Revenue Grew 6.6% y/y, Adj. Net Revenue Grew 5.8% y/y in Fiscal Fourth Quarter 2025 Backlog Reached New Record with TTM Book-to-Bill Ratio of 1.1x Returned a Record $1.1 billion Through Repurchases and Dividends in Fiscal 2025 Fiscal 2026 Guidance for 16% Growth in Adj. EPS, at Midpoint DALLAS, Nov. 20, 2025 /PRNewswire/ -- Jacobs Solutions Inc. (NYSE: J) today announced its financial results for the fiscal fourth quarter and fiscal year ended September 26, 2025. ...

(all amounts are expressed in millions of U.S. dollars, excluding per share amounts and unless otherwise stated) TORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Real Matters Inc. (TSX: REAL) (“Real Matters” or the “Company”), a leading network management services platform for the mortgage and insurance industries, today announced its financial results for the fourth quarter and fiscal year ended September 30, 2025. “Our business demonstrated resilience and competitive strength throughout 2025 as we consistently ...

At PropNotes, we focus on finding high-yield investment opportunities for individual investors.With our background in professional Prop Trading, we make complex concepts easy to understand and offer clear, actionable insights to help you achieve better returns.All of the analysis we produce is designed to help you make smart decisions in the market, backed by expert research you won't find anywhere else.Follow us today and take control of your portfolio.Analyst’s Disclosure:I/we have a beneficial long posit ...

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

TEL AVIV, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system (CNS) disorders, in which SciSparc holds a controlling interest of approximately 75%, has advanced its collaboration with Clearmind Medicine Inc. by filing an Israeli patent application for an innovative combination therapy of ...

Nov 20, 2025 6:40 AM Eastern Standard Time Bain Capital GSS Investment Corp. Announces the Separate Trading of its Ordinary Shares and Warrants Commencing November 20, 2025 Share BOSTON--(BUSINESS WIRE)--Bain Capital GSS Investment Corp. (NYSE: BCSS.U) (the "Company†), a blank check company, today announced that, commencing November 20, 2025, holders of the units sold in the Company's initial public offering may elect to separately trade shares of the Company's Class A ordinary shares and warrants include ...

New listings bring 21shares’ total Nordic offering to 16 products, underscoring continued demand for regulated crypto investment exposureZURICH, Nov. 20, 2025 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency exchange-traded products (ETPs), today announced the cross-listing of six additional products on Nasdaq Stockholm, further strengthening its presence in the Nordic region and reinforcing its commitment to expanding regulated, transparent, and institutional-grade access ...

The news comes a day after Air France-KLM said it submitted a bid to purchase a stake in TAP. ...

Gloo Holdings made its debut on the Nasdaq this week, putting fresh focus on faith-based investing, a small but growing segment where investors choose companies that reflect their religious values. ...

At the CEF/ETF Income Laboratory , we manage ~8%-yielding closed-end fund (CEF) and exchange-traded fund (ETF) portfolios to make income investing easy for you. Check out what our members have to say about our service.In keeping with my continued coverage on bond funds, thought to have another look at the VanEck Short High Yield Muni ETF (BATS: SHYD ). SHYD offers investors a tax-advantaged 3.5% dividend yield, with few other importantJuan de la Hoz has worked as a fixed income trader, financial analyst, op ...